These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27162653)

  • 1. Prevalence of neutralizing antibodies to common respiratory viruses in intravenous immunoglobulin and in healthy donors in southern China.
    Tian X; Jiang Z; Ma Q; Liu Q; Lu X; Liu W; Liao X; Zhou R; Su X; Luo Q
    J Thorac Dis; 2016 May; 8(5):803-12. PubMed ID: 27162653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
    Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
    Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China.
    Liu Z; Wu S; Xian Y; Gu Z; Liu W; Chen D; Zhou R
    J Med Virol; 2022 Sep; 94(9):4378-4382. PubMed ID: 35474462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses.
    Orange JS; Du W; Falsey AR
    Front Immunol; 2015; 6():431. PubMed ID: 26379667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors.
    Cao RY; Han JF; Jiang T; Tian X; Yu M; Deng YQ; Qin ED; Qin CF
    J Clin Virol; 2011 Aug; 51(4):246-9. PubMed ID: 21641277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China.
    Wang X; Xing M; Zhang C; Yang Y; Chi Y; Tang X; Zhang H; Xiong S; Yu L; Zhou D
    Emerg Microbes Infect; 2014 May; 3(5):e30. PubMed ID: 26038738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
    Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
    Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
    Wasserman RL; Lumry W; Harris J; Levy R; Stein M; Forbes L; Cunningham-Rundles C; Melamed I; Kobayashi AL; Du W; Kobayashi R
    J Clin Immunol; 2016 Aug; 36(6):590-9. PubMed ID: 27324887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
    Falsey AR; Koval C; DeVincenzo JP; Walsh EE
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
    Wasserman RL; Greener BN; Mond J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.
    Gruber WC; Wilson SZ; Throop BJ; Wyde PR
    Pediatr Res; 1987 Mar; 21(3):270-4. PubMed ID: 3550674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term monitoring of virus antibody titers in human intravenous immunoglobulin lots derived from donors in Japan.
    Onodera H; Nakagawa R; Nakagawa H; Urayama T; Haino K; Yunoki M
    Transfusion; 2018 Nov; 58(11):2617-2626. PubMed ID: 30284288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
    Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Neutralizing Antibodies to Human Adenovirus Type 4 and 7 in Healthy Populations From Southern China.
    Ye X; Xiao L; Zheng X; Wang J; Shu T; Feng Y; Liu X; Su W; Wang Q; Li C; Chen L; Feng L
    Front Microbiol; 2018; 9():3040. PubMed ID: 30619131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin.
    Onodera H; Urayama T; Hirota K; Maeda K; Kubota-Koketsu R; Takahashi K; Hagiwara K; Okuno Y; Ikuta K; Yunoki M
    Biologics; 2017; 11():23-30. PubMed ID: 28331286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.